Bex, Axel
Haanen, John
Article History
First Online: 2 July 2018
Competing interests
: A.B. has served on the advisory boards of Bristol-Myers Squibb (BMS), Genentech, Ipsen, Novartis, Pfizer, and Roche. All remunerations were made to an institutional account. He was the principle investigator of the European Organisation for Research and Treatment of Cancer (EORTC) SURTIME trial that was in part funded by an educational grant from Pfizer to the EORTC. J.H. has served on the advisory boards of BMS, Genentech, Merck, Novartis, Pfizer, and Roche. All remunerations were made to an institutional account.